Design, synthesis, and dopamine receptor modulating activity of diketopiperazine peptidomimetics of L-prolyl-L-leucylglycinamide

Journal of Medicinal Chemistry

Volumn 40, Issue 22, 1997, Pages 3594-3600

  Baures, Paul W ^a   Ojalar, William H ^b   Costain, Willard J ^c   Ott, Michael C ^c   Pradhan, Ashish ^c   Gleason, William B ^a,b   Mishra, Ram K ^c   Johnson, Rodney L ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE RECEPTOR; PIPERAZINEDIONE; PROLYLLEUCYLGLYCINAMIDE;

AMINO TERMINAL SEQUENCE; ARTICLE; COMPETITIVE INHIBITION; CONFORMATIONAL TRANSITION; CRYSTAL STRUCTURE; DOPAMINERGIC TRANSMISSION; DRUG DESIGN; DRUG SYNTHESIS; ENZYME STRUCTURE; HYDROGEN BOND; NONHUMAN; RECEPTOR AFFINITY;

ANIMALS; BEHAVIOR, ANIMAL; CATTLE; CORPUS STRIATUM; DOPAMINE AGENTS; DRUG DESIGN; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MOLECULAR MIMICRY; MOLECULAR STRUCTURE; MSH RELEASE-INHIBITING HORMONE; PIPERAZINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE; SPECTROMETRY, MASS, FAST ATOM BOMBARDMENT; X-RAY DIFFRACTION;

EID: 0030681243     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm970328b     Document Type: Article

References (21)

1. Chiu, S.; Paulose, C. S.; Mishra, R. K. Effect of L-Prolyl-L-Leucyl-Glycinamide (PLG) on Neuroleptic-Induced Catalepsy and Dopamine/Neuroleptic Receptor Bindings. Peptides 1981, 2, 105-111.
2. 2 Receptor: Evidence for Modulation of Agonist Affinity States in Bovine Striatal Membranes. J. Neurochem. 1988, 50, 960-967.
3. 2. J. Med. Chem. 1988, 37, 1430-1436.
4. 2 Receptor by L-Pro-L-Leu-Glycinamide (PLG) Analogue 3(R)-(N-L-Prolylamino)-2-oxo-1-pyrrolidineacetamide. Prog. Neuro-Psychopharmacol. Biol. Psy. chiatr. 1990, 14, 821-827.
5. 2. J. Med. Chem. 1993, 36, 256-263.
6. 2. J. Med. Chem. 1993, 36, 2356-2361.
7. 2. J. Med. Chem. 1993, 36, 3481-3483.
8. Baures, P. W.; Ojala, W. H.; Gleason, W. B.; Mishra, R. K.; Johnson, R. L. Design, Synthesis, X-ray Analysis, and Dopamine Receptor-Modulating Activity of Mimics of the "C5" Hydrogen-Bonded Conformation in the Peptidomimetic 2-Oxo-3(R)-[(2(S)-pyrrolidinylcarbonyl)amino]-1-pyrrolidineacetamide. J. Med. Chem. 1994, 37, 3677-3683.
9. 2. Int. J. Pept. Protein Res. 1989, 33, 181-190.
10. Diafi, L.; Couquelet, J.; Tronche, P.; Gardette, D.; Gramain, J.-C. 8-Hydroxylated Derivatives of Diazabicyclo[4.3.0]nonanes, 2,5-Dioxodiazabicyclo[4.3.0]nonanes and Some Related Esters. J. Heterocycl. Chem. 1990, 27, 2181-2187.
11. The authors have deposited atomic coordinates for these structures with the Cambridge Crystallographic Data Centre. The coordinates can be obtained, upon request, from the Director, Cambridge Crystallographic Data Centre, 12 Union Road, Cambridge CB2 1EZ, U.K.
12. 3 = 80°.
13. Ott, M. C.; Mishra, R. K.; Johnson, R. L. Modulation of Dopaminergic Neurotransmission in the 6-Hydroxydopamine Lesioned Rotational Model by Peptidomimetic Analogues of L-Prolyl-L-leucyl-glycinamide. Brain Res. 1996, 737, 287-291.
14. 2 (PLG). Peptides 1997, in press.
15. North, A. C. T.; Phillips, D. C.; Mathews, F. S. A Semi-empirical Method of Absorption Correction. Acta Crystallogr. 1968, 24A, 351-359.
16. Sheldrick, G. M. SHELXS86. Program for the Solution of Crystal Structures; University of Göttingen: Germany, 1986.
17. TEXSAN-TEXRAY Structure Analysis Package, Molecular Structure Corp., 3200 Research Forest Dr., The Woodlands, TX 77381; 1985.
18. 2 Receptors and Modulation of Affinity States by Guanine Nucleotides in Cholate-Solubilized Bovine Striatal Preparations. J. Neurochem. 1986, 47, 1493-1502.
19. Kazmi, S. M. I.; Mishra, R. K. Comparative Pharmacological Properties and Functional Coupling of μ and δ Opioid Receptor Sites in Human Neuroblastoma SH-SY5Y Cells. Mol. Pharmacol. 1987, 32, 109-118.
20. 50) of an Enzymatic Reaction. Biochem. Pharmacol. 1973, 22, 3099-3108.
21. Paxinos, G.; Watson, C. The Rat Brain in Stereotaxic Coordinates; Academic Press: Toronto, 1986. †Department of Medicinal Chemistry.